ResultsIQ › Latest results › Nephrocare Health Services Limited
Nephrocare Health Services Limited Q4 FY26 earnings call summary
NSE: NEPHROPLUS · BSE: 544647
Earnings call of 20 May 2026, summarised by AI from the filing.
NephroPlus FY26 revenue rose 32.2% to ₹998.8 cr and adjusted PAT 74.6% to ₹128.3 cr, with a 15% to 20% revenue CAGR guidance maintained over three to four years.
Key takeaways
- Guidance Management maintains a 15% to 20% revenue CAGR over three to four years and gives no annual guidance.
- Q4 margin Q4 adjusted EBITDA margin fell to 20.9% from 24.6% on a one-time ECL provision of ₹10 cr; excluding it, margin was 25%.
- Saudi Arabia Saudi remains in the investment phase with a ₹3 cr JV loss; the MOH tender is at EOI stage.
Nephrocare Health Services Limited Q1 FY27 results
As filed: Revenue ₹282 cr, EBITDA ₹63.9 cr, PAT ₹32.0 cr, EBITDA margin 22.7%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹282 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹266 cr, EBITDA ₹53.8 cr, PAT ₹30.4 cr, EBITDA margin 20.2%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹266 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.3% in 30 days (Nifty 500: +3.0%).
- Q3 FY26: Revenue ₹260 cr, EBITDA ₹60.9 cr, PAT ₹32.2 cr, EBITDA margin 23.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹260 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +4.5% in 30 days (Nifty 500: −7.8%).
Past price moves after results do not indicate future moves. Not a recommendation.
Nephrocare Health Services Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (12 Aug 2026), Results deck (11 Aug 2026), Results press release (11 Aug 2026)
- Q4 FY26: Earnings call (20 May 2026), Results deck (19 May 2026), Results press release (19 May 2026)
- Q3 FY26: Earnings call (11 Feb 2026), Results deck (10 Feb 2026), Results press release (10 Feb 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.